Peyroni

Ralph, D. J., Brooks, M. D., Bottazzo, G. F., & Pryor, J. P. (1992). The treatment of Peyronie's disease with tamoxifen. British journal of urology, 70(6), 648-651.

de la Peyronie, F. (1743). Sur quelques obstacles qui s' opposent a l'ejaculation naturelle de la semence. Mem Acad R Chir, 1(1743), 425-34.

Mulhall, J. P., Creech, S. D., Boorjian, S. A., Ghaly, S., Kim, E. D., Moty, A., ... & Hellstrom, W. (2004). Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. The Journal of urology, 171(6 Part 1), 2350-2353.

Levine, L. A., Benson, J., & Hoover, C. (2010). Inflatable penile prosthesis placement in men with Peyronie’s disease and drug-resistant erectile dysfunction: a single-center study. The journal of sexual medicine, 7(11), 3775-3783.

Terrier, J. E., & Nelson, C. J. (2016). Psychological aspects of Peyronie’s disease. Translational andrology and urology, 5(3), 290.

Gelbard, M. K., Dorey, F., & James, K. (1990). The natural history of Peyronie’s disease. The Journal of urology, 144(6), 1376-1379.

Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997). Proposal: trauma as the cause of the Peyronie's lesion. The Journal of urology, 157(1), 285-290.

Schmidt, J., Goode, D., Flannigan, R., & Mohammadi, H. (2023). A review of the experimental methods and results of testing the mechanical properties of Tunica Albuginea. Journal of Medical Engineering & Technology, 47(4), 234-241.

Diegelmann, R. F. (1997). Cellular and biochemical aspects of normal and abnormal wound healing: an overview. The Journal of urology, 157(1), 298-302.

Gonzalez-Cadavid, N. F., & Rajfer, J. (2005). Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease. Nature clinical practice Urology, 2(6), 291-297.

Shindel, A. W., Lin, G., Ning, H., Banie, L., Huang, Y. C., Liu, G., ... & Lue, T. F. (2010). Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. The journal of sexual medicine, 7(6), 2077-2085.

Levine, L. A. (2006). Peyronie's disease and erectile dysfunction: Current understanding and future direction. Indian Journal of Urology, 22(3), 246-250.

El-Sakka, A. I., Salabas, E., Dincer, M., & Kadioglu, A. (2013). The pathophysiology of Peyronie’s disease. Arab journal of urology, 11(3), 272-277.

Hauck, E. W., Hackstein, N., Vosshenrich, R., Diemer, T., Schmelz, H. U., Bschleipfer, T., ... & Weidner, W. (2003). Diagnostic value of magnetic resonance imaging in Peyronie’s disease—a comparison both with palpation and ultrasound in the evaluation of plaque formation. European urology, 43(3), 293-300.

Bivalacqua, T. J., Champion, H. C., & Hellstrom, W. J. G. (2002). Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. International journal of impotence research, 14(5), 345-352.

Tal, R., Hall, M. S., Alex, B., Choi, J., & Mulhall, J. P. (2012). Peyronie’s disease in teenagers. The journal of sexual medicine, 9(1), 302-308.

Taylor, F. L., & Levine, L. A. (2007). Peyronie's disease. Urologic Clinics of North America, 34(4), 517-534.

Ralph, D. J., Brooks, M. D., Bottazzo, G. F., & Pryor, J. P. (1992). The treatment of Peyronie's disease with tamoxifen. British journal of urology, 70(6), 648-651.

de la Peyronie, F. (1743). Sur quelques obstacles qui s' opposent a l'ejaculation naturelle de la semence. Mem Acad R Chir, 1(1743), 425-34.

Mulhall, J. P., Creech, S. D., Boorjian, S. A., Ghaly, S., Kim, E. D., Moty, A., ... & Hellstrom, W. (2004). Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. The Journal of urology, 171(6 Part 1), 2350-2353.

Levine, L. A., Benson, J., & Hoover, C. (2010). Inflatable penile prosthesis placement in men with Peyronie’s disease and drug-resistant erectile dysfunction: a single-center study. The journal of sexual medicine, 7(11), 3775-3783.

Terrier, J. E., & Nelson, C. J. (2016). Psychological aspects of Peyronie’s disease. Translational andrology and urology, 5(3), 290.

Gelbard, M. K., Dorey, F., & James, K. (1990). The natural history of Peyronie’s disease. The Journal of urology, 144(6), 1376-1379.

Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997). Proposal: trauma as the cause of the Peyronie's lesion. The Journal of urology, 157(1), 285-290.

Schmidt, J., Goode, D., Flannigan, R., & Mohammadi, H. (2023). A review of the experimental methods and results of testing the mechanical properties of Tunica Albuginea. Journal of Medical Engineering & Technology, 47(4), 234-241.

Diegelmann, R. F. (1997). Cellular and biochemical aspects of normal and abnormal wound healing: an overview. The Journal of urology, 157(1), 298-302.

Gonzalez-Cadavid, N. F., & Rajfer, J. (2005). Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease. Nature clinical practice Urology, 2(6), 291-297.

Shindel, A. W., Lin, G., Ning, H., Banie, L., Huang, Y. C., Liu, G., ... & Lue, T. F. (2010). Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. The journal of sexual medicine, 7(6), 2077-2085.

Levine, L. A. (2006). Peyronie's disease and erectile dysfunction: Current understanding and future direction. Indian Journal of Urology, 22(3), 246-250.

El-Sakka, A. I., Salabas, E., Dincer, M., & Kadioglu, A. (2013). The pathophysiology of Peyronie’s disease. Arab journal of urology, 11(3), 272-277.

Hauck, E. W., Hackstein, N., Vosshenrich, R., Diemer, T., Schmelz, H. U., Bschleipfer, T., ... & Weidner, W. (2003). Diagnostic value of magnetic resonance imaging in Peyronie’s disease—a comparison both with palpation and ultrasound in the evaluation of plaque formation. European urology, 43(3), 293-300.

Bivalacqua, T. J., Champion, H. C., & Hellstrom, W. J. G. (2002). Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. International journal of impotence research, 14(5), 345-352.

Tal, R., Hall, M. S., Alex, B., Choi, J., & Mulhall, J. P. (2012). Peyronie’s disease in teenagers. The journal of sexual medicine, 9(1), 302-308.

Taylor, F. L., & Levine, L. A. (2007). Peyronie's disease. Urologic Clinics of North America, 34(4), 517-534.